Literature DB >> 207477

Hexoprenaline: beta-adrenoreceptor selectivity in isolated tissues from the guinea-pig.

S R O'Donnell, J C Wanstall.   

Abstract

1. A catecholamine beta-adrenoreceptor agonist, hexoprenaline, was examined in vitro on five guinea-pig tissues and its potency relative to isoprenaline (as 100) obtained. 2. Hexoprenaline clearly delineated between those tissues classified as containing beta2-adrenoreceptors (trachea, hind limb blood vessels and uterus; relative potencies 219, 110 and 76 respectively) and those classified as containing beta1-adrenoreceptors (atria and ileum; relative potencies 3.3 and 1.0 respectively). 3. Hexoprenaline differed from some previously studied noncatecholamine beta-adrenoreceptor agonists in being only two-fold less potent, relative to isoprenaline, as a vasodilator in perfused hind limb than as a tracheal relaxant.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 207477     DOI: 10.1111/j.1440-1681.1975.tb01859.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

1.  An in vitro comparison of beta-adrenoceptor stimulants on potassium-depolarized uterine preparations from guinea-pigs.

Authors:  S R O'Donnell; C G Persson; J C Wanstall
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

2.  In vitro activity of RO363, a beta1-adrenoceptor selective agonist.

Authors:  D Iakovidis; E Malta; G A McPherson; C Raper
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

3.  The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.

Authors:  P Bremner; C Burgess; G Purdie; R Beasley; J Crane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.